show episodes
 
The Life Sciences D’n’A podcast is hosted by Dr. Amar Drawid, an industry veteran and AI expert who has worked in data science leadership with top biopharmaceutical companies. He explores the evolving use of AI and data science with innovators working to reshape all aspects of the biopharmaceutical industry from the way new therapeutics are discovered to how they are marketed.
  continue reading
 
Artwork

1
Psychedelics Today

Psychedelics Today

Unsubscribe
Unsubscribe
Weekly+
 
Psychedelics Today is the planetary leader in psychedelic education, media, and advocacy. Covering up-to-the-minute developments and diving deep into crucial topics bridging the scientific, academic, philosophical, societal, and cultural, Psychedelics Today is leading the discussion in this rapidly evolving ecosystem.
  continue reading
 
Let’s Talk PR & More, hosted by Sherry Goldman of Goldman Communications Group, features an in-depth conversation with an industry leader sharing their insights and expertise on an aspect of public relations and/or the disciplines and issues that impact public relations. Topics range from the PR industry, best practices, profiles of industry leaders, related industries including the media, marketing, and advertising, and issues that impact communications and PR, such as AI. Let’s Talk PR & M ...
  continue reading
 
Artwork

1
Go Fund This!

Southgate Media Group

Unsubscribe
Unsubscribe
Monthly
 
Go Fund This! finds current, running crowdfunding projects and sits down with their project managers to discuss their projects more in-depth. We focus on Kickstarters, Indie GoGos, Patreons, and other projects needing funding and we interview the people involved to help them get the word out. Games, comics, movies, books, music, and more! We cover it all.
  continue reading
 
Loading …
show series
 
One of the key obstacles to developing new drugs and diagnostics is the lack of access to longitudinal biological and clinical patient data. Culmination Bio, a spin-out of Intermountain Health, is building the largest patient data platform with more than 40 years of de-identified patient electronic health records and biospecimen data. We spoke to L…
  continue reading
 
In this episode, Joe interviews Joanna Kempner, Ph.D.: associate professor in the Department of Sociology at Rutgers University and author of the recently released, Psychedelic Outlaws: The Movement Revolutionizing Modern Medicine. The book profiles the history and groundbreaking work of ClusterBusters, a nonprofit researching and spreading awarene…
  continue reading
 
Sherry Goldman's guest is Andrew Bergin, founder and managing partner of Speaking Virtually. Sherry and Andy discuss the keys to effective and effortless communication. Let’s Talk PR & More!, hosted by Sherry Goldman, president of the award-winning Goldman Communications Group, is an in-depth conversation on a topic or issue related to public relat…
  continue reading
 
In this episode, Kyle interviews Mustapha Khan: Emmy Award-winning director with over 100 film and television credits, who has worked with clients such as Coca-Cola and Honda, and celebrities ranging from Maya Angelou to Snoop Dogg. Khan is finalizing a film about Lenny and Elizabeth Gibson and their ongoing work at Dreamshadow – the people and com…
  continue reading
 
NAMPT is a critical enzyme that regulates how cells use energy. It can also play an important role in the ability of cancer cells to survive, grow, and spread. While it’s been recognized as a potential target to treat certain cancers, developing NAMPT inhibitors have been challenging because they can disrupt energy metabolism in healthy cells. Reme…
  continue reading
 
In this episode, Joe interviews Danielle Nova: founder of Psychedelic Recovery, founding team member of Decriminalize Nature Oakland, and Executive Director of the San Francisco Psychedelic Society. As a recovering addict, Nova discusses how working with psychedelics helped her find her way to recovery, and how she's spreading that knowledge to oth…
  continue reading
 
In this episode of Vital Psychedelic Conversations, David interviews Deanna Rogers: Registered Clinical Counselor and Vital instructor. She discusses how trauma grows in our bodies, and the importance of practitioners and facilitators becoming trauma-informed before working with clients. She stresses the need to create the right conditions for clie…
  continue reading
 
The emergence of CRISPR, a powerful tool for gene editing, promises to correct devastating genetic diseases, but it also raises concerns about how it will be used and who will make those decisions. Neal Baer, in his new book “The Promise and Peril of CRISPR,” brings together a series of essays by bioethicists, geneticists, and others who explore et…
  continue reading
 
In this episode, Joe interviews Jean Lacy: Executive Director of the Illinois Psychedelic Society; and La Shawn K. Ford: 17-year member of the Illinois House of Representatives, representing the 8th District. Together, they are working on the CURE (Compassionate Use and Research of Entheogens) Act, which aims to decriminalize plant medicines and br…
  continue reading
 
In this episode of Vital Psychedelic Conversations, David interviews Rachelle Sampson, Ph.D.: researcher and founder of Blue Prism Coaching; and Bennet Zelner, Ph.D.: researcher, speaker, and creator of the Pollination Approach. They are both Vital instructors and Associate Professors at the Robert H. Smith School of Business, University of Marylan…
  continue reading
 
Speeding Protein Engineering with Whether it’s the development of new biotherapeutics, or replacing hydrocarbons from their role in industrial manufacturing, engineering proteins suited for a task is a time consuming and expensive process. Cradle Bio has developed generative AI technology to accelerate protein engineering by reducing the number of …
  continue reading
 
As the psychedelic renaissance continues to spread throughout the West, we learn more about these substances and experiences every day. But are we losing the important ancestral teachings and Indigenous knowledge that got us here? In this episode, Kyle interviews Alonso Del Río: author, musician, filmmaker, founder of the Center for Healing and Con…
  continue reading
 
Sherry Goldman's guest is Margaret Myers, director of editorial at Long Dash. Sherry and Marge discuss effective storytelling and how the 'editorial difference' can enable brands and organizations to better develop messages and communications that will engage audiences authentically. Let’s Talk PR & More!, hosted by Sherry Goldman, president of the…
  continue reading
 
In this episode of VItal Psychedelic Conversations, Vital instructor, Diego Pinzon hosts his first podcast, interviewing Vital graduate and clinically-trained psychologist, “The Kinki Buddhist”: Kate Amy. As Amy’s interest in psychedelics grew, she began to see a clear intersection between psychedelic states and the non-ordinary states she’d reache…
  continue reading
 
With the emergence of GLP-1 agonists to treat obesity, there has been growing interest in the use of peptide-based medicines. Protagonist Therapeutics has developed technology that can take these target specific and potent therapies and allow them to be delivered orally. The company has a collaboration with Johnson & Johnson for an oral peptide tha…
  continue reading
 
In this episode, Chris Koddermann interviews two members of the Center for the Neuroscience of Psychedelics at Mass General Hospital: founding director, author, and co-founder of three drug development companies, Dr. Jerry Rosenbaum; and psychiatrist and associate director and director of cognitive neuroscience, Sharmin Ghaznavi, MD, Ph.D. Rosenbau…
  continue reading
 
Sherry Goldman's guest is Dick Grove, founder and CEO of INK Inc Public Relations. Sherry and Dick discuss the changes in the PR industry, changing agency-client relations and relationships, including the retainer model, and the importance of earned media in PR programs. Let’s Talk PR & More!, hosted by Sherry Goldman, president of the award-winnin…
  continue reading
 
In this episode of Vital Psychedelic Conversations, David interviews Tiffany Hurd: microdosing coach, speaker, business leadership advisor, and student in our current cohort of Vital. After 15 years in the corporate healthcare industry and several years on antidepressants, she started microdosing psilocybin and saw an immediate change in her life, …
  continue reading
 
John Carter, science fiction’s original and greatest hero, returns in a multi-cast audio drama starring Sean Patrick Flanery of Young Indiana Jones and The Boondock Saints in the title role! We're also offering a role-playing game supplement compatible with both the Fifth Edition of the world's most popular RPG and OSR ("Old School Revival") rules,…
  continue reading
 
While there have been a parade of novel therapeutic modalities in recent years, many of them are constrained by delivery challenges. Vesigen Therapeutics is developing novel drug delivery technology known as ARMMs that can transport a wide range of therapeutic payloads directly into the cytoplasm of target cells. We spoke to Paulash Mohsen, CEO of …
  continue reading
 
The path of the psychedelic renaissance has largely touched on the aspects of therapy, personal growth, and initiation rites, but now, the relationship between psychedelics and creativity is being studied more and more. Can psychedelics really increase intellect, novelty, and problem solving? In this episode, Joe interviews Dr. Bruce Damer: astrobi…
  continue reading
 
Sherry Goldman's guest is Jerry Barmash, a New York area broadcaster and reporter and author of the new book Here Now The News. Sherry and Jerry talk about Jerry's new book Here Now The News, which focuses on the stories of local TV news anchors and reporters, discussing how broadcast talent both reflects and also shapes the news covered. Let’s Tal…
  continue reading
 
Jungian psychology takes a fascinating look at the relationship between the conscious and unconscious parts of our minds. How is this framework brought more to the forefront through psychedelics and an understanding of our many parts? In this episode of Vital Psychedelic Conversations, Johanna interviews Jung experts and Vital instructors: Maria Pa…
  continue reading
 
The body has a natural mechanism for breaking down and clearing proteins. Arvinas is among a group of companies that’s seeking to harness this mechanism for therapeutic purposes. It has platform technology that enables the development of targeted protein degraders to breakdown disease-causing proteins. Among the benefits of this approach is that it…
  continue reading
 
As many mushroom enthusiasts will attest: the more you learn about the fungal kingdom, the more you see how important mushrooms are to every ecosystem they’re a part of – and how life-changing a relationship with them can be. In this episode, Joe interviews Jasper Degenaars: mycologist, educator, and the Hyphae Headmaster at Fungi Academy, offering…
  continue reading
 
Rob interviews artist, Zack Howe, about the Kickstarter for the new card game, "Havoc: Gen Zero". Check out the trailer! https://www.youtube.com/watch?v=LEjSMySlK6k Instagram https://www.instagram.com/havoctcg/ Facebook https://www.facebook.com/havoctcg/ Discord https://discord.gg/zeJvEgHT X https://x.com/HAVOCtcg Website enterhavoc.com +++++++++++…
  continue reading
 
Sherry Goldman's guest is Ray Hennessey, CEO and executive partner of Vocatus and author of the book Beyond Sorry: How to Own Up, Make Good and Move Forward After a Crisis. Sherry and Ray discuss crisis communications and best practices for corporate apologies. Let’s Talk PR & More!, hosted by Sherry Goldman, president of the award-winning Goldman …
  continue reading
 
Psychedelics in palliative care has become an exciting new framework for people looking to ease anxiety and embrace spirituality, but the concept is not as simple as just providing a substance. In this episode, Joe interviews Livi Joy: Director of Health and Safety, Existential Palliative Ministry Lead Facilitator, and more at Sacred Garden Communi…
  continue reading
 
The traditional approach to treating autoimmune disease has relied on ways to suppress the immune system. COUR Pharmaceuticals is developing first-in-class therapies that instead seek to reprogram the immune system to create antigen-specific tolerance. We spoke to COUR CEO John Puisis and COUR Vice President of Research Adam Elhofy, about how the c…
  continue reading
 
In this episode, Joe interviews Erica Rex, MA: award-winning journalist, past guest, thought leader on psychedelic medicine, and participant in one of the first clinical trials using psilocybin to treat cancer-related depression. She tells the story of her recent harrowing experience, brought on by 6 times the amount of Syrian rue that was recommen…
  continue reading
 
Sherry Goldman's guest in Kerri Allen, senior managing director of Applecart. Sherry and Kerri discuss the growing role of data in PR, how data and the digital landscape are changing what PR and do and evaluate, and decision-maker marketing. Let’s Talk PR & More!, hosted by Sherry Goldman, president of the award-winning Goldman Communications Group…
  continue reading
 
In this episode of Vital Psychedelic Conversations, Johanna interviews Monica Nieto: Vital graduate, psychedelic facilitator and integration coach, and founder of Holistic TherapeutiX, a retreat center offering cannabis and breathwork retreats; and Jordana Ma: past Vital instructor and psychological counselor who runs retreats in Peru following the…
  continue reading
 
The next blockbuster drug may already be in production by bacteria within your body. Bacteria produce unique chemical compounds that are bioactive and may have great therapeutic potential, but this chemical space has largely not been mined. Empress Therapeutics, a Flagship Pioneering company, is searching for such molecules by exploring the genes o…
  continue reading
 
In this episode, Joe interviews Jon Reiss: critically acclaimed filmmaker, author, and host of the Plantscendence podcast, which tells people’s psychedelic stories and is beginning its second season soon. He talks about his early days of directing Nine Inch Nails and Type O Negative videos, and how Plantscendence was born after he realized that the…
  continue reading
 
Sherry Goldman's guest is Jerry Pionk, owner and principal of Xcelsior Communications. Sherry and Jerry discuss AI and how government entities are using AI in PR and communications initiatives. Jerry shares his experiences using AI and handling communications in key government roles, including for the King County Department of Local Services in Sea…
  continue reading
 
In this episode of Vital Psychedelic Conversations, David interviews Sara Reed: Vital instructor, lecturer, and lead psychedelic research therapist at Imperial College London; and Alex H. Robinson: Vital student, integration coach and psilocybin facilitator for Heroic Hearts Project, and distinguished Army SOF combat Veteran with a decade of active…
  continue reading
 
In most cases, the immune system detects and destroys cells that could become cancerous every day. For cancer to ravage the body, it needs to evade the immune system by shutting off its response. SIRPant Immunotherapeutics is seeking to address cancer by activating and modifying a patient’s own macrophages to awaken the immune system to cancer. The…
  continue reading
 
Loading …

Quick Reference Guide